AXTIAXT, Inc.

$68.47+1478% 1Y

Is the business good?

Mixed

The checks split: margins widening, but 2 of 9 health tests passed.

1 good, 1 to watch, 2 without data
Fundamental health (F-score)2 / 9SEC EDGAR · Dec 31, 2025

Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.

Margin direction, 3 years+11.4 ptsderived

Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Leverage (Debt/EBITDA)behind 86% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is AXTI?

AXT, Inc. earns 0.55% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

0.55%

Return on invested capital · cost of capital 9.0% · 8.5 points below what the capital costs: growth destroys value

Operating margin
3.1%

Operating margin · Semiconductor Equipment & Materials median 11% · 12 months to Q2 2026

Share count, year on year
+45%

Share count, year on year · shareholders own a smaller slice than a year ago

R&D as % of revenue
8.0%

R&D as % of revenue

Operating margin by fiscal year
YearOperating margin
FY20204.1%
FY20219.4%
FY20228.9%
FY2023−28%
FY2024−15%
FY2025−25%
Details›
Gross margin12 months to Q2 2026
32%
Operating margin12 months to Q2 2026
3.1%
Net margin12 months to Q2 2026
3.2%
Free cash flow margin
−16%
R&D as % of revenue
8.0%
Revenue, trailing twelve months
$126M
Free cash flow, trailing twelve months
−$20M
Net income, trailing twelve months
$4.1M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
0.55%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.